In summary, our analysis revealed that, in addition to classical cardiovascular risk factors, IL-6 is independently associated with the presence of subclinical atherosclerosis in PLWH with long-term controlled viral replication, underscoring the relevance of IL-6 as both a marker and a potential therapeutic target in the management of HIV-associated cardiovascular disease. This evidence concerns the gene IL6 and cardiovascular disorder.